com/cgi-bin/prnh/20000207/FILENETLOGO)

What:
FileNet will hold its first annual FileNet Europe, Middle East and Africa
(EMEA) UserNet conference on June 1-3, 2005 in Prague, Czech Republic.
The event brings together customers from across the region and provides
an opportunity for customers and partners to share ideas and network with
other FileNet customers, colleagues and peers to gain valuable knowledge
and insights to help maximize their business performance using FileNet
solutions.

In conjunction with the event, FileNet also will host its FileNet
Developers Conference and the UserNet ECM Storage Forum, sponsored by
Hitachi Data Systems, Network Appliance, Plasmon and Sun Microsystems . The findings from ORION showed that CRESTOR 5 mg and
40 mg reduced LDL-C from baseline by 39 percent and 58 percent, respectively
(p<0. It is a member of the statin (HMG-CoA reductase
inhibitors ) class of drug therapy. For patients with
hypercholesterolemia and mixed dyslipidemia, the usual recommended starting
dose of CRESTOR is 10 mg.g. Patients should be advised to promptly
report unexplained muscle pain, tenderness, or weakness, particularly if
accompanied by malaise or fever .3%) and nausea (1.
A full copy of the prescribing information for CRESTOR is available at
http: //www.4 billion and leading positions in sales of gastrointestinal,
cardiovascular, respiratory, oncology and neuroscience products.

classical conspiracy

Utopy Announces New White Paper -- Speech Analytics Empowers Root Cause Analysis; Utopy Highlights the Benefits of Speech Analytics for Business Process Re-eng

It is available at
http: //www.com,
email info@utopy.com

Utopy, SpeechMiner, SpeechMiner Enterprise, SpeechMiner
Root -Cause, SpeechMiner Customer Satisfaction and Deliberate
Listening, are registered trademarks or trademarks of Utopy, Inc.

New Study on Effects of CRESTOR on Carotid Atherosclerosis Presented at European Atherosclerosis Society Congress

CRESTOR reduced the proportion of lipid-rich necrotic core (LRNC)
in the most diseased area of atherosclerotic plaques by 17.

Important Safety Information
CRESTOR is contraindicated in patients with active liver disease or
unexplained persistent elevations of serum transaminases, in women who
are pregnant or may become pregnant, and in nursing mothers.6 billion healthcare business with more than
12,000 employees.com.

s insights

FileNet European Customers to Share Successes at User Conference - EMEA UserNet 2005

newscom.
FileNet ECM products are designed to deliver a broad set of capabilities
that integrate with existing information systems to provide cost-effective
solutions that solve real-world business problems.

Business Editors/High-Tech Editors

SAN FRANCISCO----Utopy, Inc."
The white paper entitled, "Speech Analytics Empowers Root Cause
Analysis," describes how speech analytics solutions support Root Cause
Analysis by highlighting what to measure, spotting trends, identifying
what is happening down to the call level, and tracking whether changes
in business processes meet design goals. All
other trademarks mentioned here are the properties of their respective
owners."
In ORION, 35 patients with moderate hypercholesterolemia and established
carotid atherosclerosis were treated with either CRESTOR 5 mg (N=15) or 40 mg
(N=20) for two years.001). CRESTOR has not been determined to prevent
heart disease, heart attacks , or strokes. CRESTOR should be prescribed with caution in patients with
predisposing factors for myopathy, such as renal impairment, advanced age, and
inadequately treated hypothyroidism.4%), asthenia (1.pdf or by calling 1-877-420-7249. AstraZeneca is listed in the Dow Jones Sustainability Index
(Global) as well as the FTSE4Good Index.

insights paper

(Logo: http://www.
Pierre Haren, CEO and chairman for ILOG, will also be presenting.

Also featured will be customer-led case studies on risk management and
compliance, efficiency improvements, business process management and
integration. There is little information providing an organized
view of why customers call , what issues they discuss, and what trends
occur in the customer and prospect relationship.5%
(p=0. The ORION study was designed to assess and visualize
the effect of CRESTOR on the composition of atherosclerotic plaques using
advanced, non-invasive and high-resolution magnetic resonance imaging (MRI)
techniques. "Prior studies
have used imaging to examine changes in the size of plaque in response to
statin therapy. No significant median (mean)
percent change in carotid artery wall volume was observed versus baseline from
baseline: 0.astrazeneca-us. It is one of the
world 's leading pharmaceutical companies with healthcare sales of over
$21. In the United
States, AstraZeneca is a $9.

republic society

Presentations will be given by a wide range of customers
including Airbus, AON, PricewaterhouseCoopers and FileNet ValueNet
partners BEA, BearingPoint and Capgemini.m.utopy. Headquartered in San Francisco, CA, Utopy's team has
extensive experience in speech analytics, contact center technology ,
mission-critical intelligence systems, and the business processes
associated with improving operating performance.
"Atherosclerosis occurs when there is a build up of fatty or fibrous
deposits to form areas called plaques in the artery wall," said Thomas
Hatsukami, Professor of Surgery at the University of Washington School of
Medicine and assistant chief of vascular surgery in the VA Puget Sound Health
Care System and principal investigator of the ORION study.2%) and -1. The most frequent
adverse events thought to be related to CRESTOR were myalgia (3.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the
research, development , manufacture and marketing of prescription
pharmaceuticals and the supply of healthcare services .

s classical

Other Activities:
EMEA UserNet attendees will also have access to the UserNet Products and
Services Pavilion, which allows customers to consult directly with
leading partners and industry experts about their specific product needs
and FileNet's latest technology and solutions., Ltd., semiannually) thereafter. The benefit of further alterations
in lipid levels by the combined use of rosuvastatin with fibrates or niacin
should be carefully weighed against the potential risks of this combination.astrazeneca-us.

s highlighting

com

The UserNet Storage Forum will be held 9 a.
Headquartered in Costa Mesa, Calif. Utopy's award-winning
and patent-pending product suite, SpeechMiner(R), identifies,
evaluates and catalogs events within person-to-person telephone
conversations, thereby transforming audio data into structured a
knowledge base, reports, and alerts for decision makers. Utopy's customers
include Fortune 500 companies as well as other innovators in contact
center operations.5%
(p=0.006), respectively.3%),
constipation (1.

republic through

Media Contacts:
Carol Thornton Jane Harris
FileNet Corporation Chameleon PR
Phone: 714-327-3746 Phone: +44 (0) 20 7721 7875
Email: jane@chameleonpr. It is the most efficient,
cost-effective and intelligent method of automatically analyzing the
data collected from those conversations, and the essential component
in developing accurate Root Cause Analyses.
This paper is Utopy's latest step in its continuing effort to
educate contact center professionals and company-wide executives on
the many benefits of Speech Analytics .aspx

About Utopy

As the leader in Speech Analytics technology, Utopy offers
solutions to improve contact center performance, support market and
sales efforts, and enhance homeland security .4% (1.

About CRESTOR
CRESTOR (rosuvastatin calcium) is a once-daily prescription medication for
use as an adjunct to diet in the treatment of various lipid disorders
including primary hypercholesterolemia , mixed dyslipidemia and isolated
hypertriglyceridemia. However, initiation of therapy with 5 mg once
daily should be considered for patients requiring less aggressive LDL-C
reductions or who have predisposing factors for myopathy, and for special
populations such as patients taking cyclosporine , Asian patients, and patients
with severe renal insufficiency. Rare cases of rhabdomyolysis
with acute renal failure secondary to myoglobinuria have been reported with
CRESTOR and with other drugs in this class. The 40-mg dose of CRESTOR is
reserved only for those patients who have not achieved their LDL-C goal
utilizing the 20 mg dose of CRESTOR once daily.
Combination therapy with rosuvastatin and gemfibrozil should generally be
avoided.

insights sallust

Featured Speakers:

FileNet CEO and chairman, Lee Roberts, will deliver the keynote address.hilton., the Company markets its innovative
ECM solutions in more than 90 countries through its own global sales,
professional services and support organizations, as well as via its
ValueNet(R) Partner network of resellers, system integrators and application
developers.

Note to editors: FileNet and ValueNet are registered trademarks of FileNet
Corporation., a
leading provider of speech analytics solutions for contact centers and
government intelligence markets, today announced the availability of a
white paper describing how speech analytics empowers root cause
analyses by processing the speech content of recorded conversations
between customers and contact center agents.

3%).

arts society

In addition to the UserNet conference, the FileNet Developers Conference
will offer users hands-on training with FileNet product experts.prague.6% (p=NS) and 35. When initiating statin therapy
or switching from another statin therapy, the appropriate CRESTOR starting
dose should first be utilized, and only then titrated according to the
patient's individualized goal of therapy. CRESTOR is generally well-tolerated.com/pi/crestor.

into sallust

Other
speakers include Richard Gompells, senior vice president of Citigroup's
technology group, and industry analyst firm META Group's Jeffrey Mann. Led by
FileNet's senior vice president for development, Kim Poindexter, the
Developer 's Conference will include a series of workshops focusing on
FileNet's latest products. All other company or product names referenced in this release
may be trademarks or registered trademarks of their respective owners.
Greg Borton, VP of Utopy Client Services, stated, "Pursuing root
cause analysis in customer contact centers is difficult since the
primary evidence providing insights into business processes -- the
conversations between customers and agents -- is available mainly as
anecdotal examples. These data were presented at the 75th European Atherosclerosis
Society Congress (EAS) .

classical arts

FileNet Customers, ValueNet Business Partners and the World's Leading Storage
Vendors Converge in Prague to Attend UserNet Conference and ECM Storage Forum

Who:
FileNet Corporation (Nasdaq: FILE), the leading provider of Enterprise
Content and Business Process Management solutions , helps organizations
make better decisions by managing the content and processes that drive
their business. to noon on Friday, June 3.
Since the Company's founding in 1982, more than 4,000 organizations,
including more than three quarters of the FORTUNE 100, have taken advantage of
FileNet solutions for help in managing their mission-critical content and
processes.com/visitors /register_download_rootcause_bwpr. In terms of individual responses to CRESTOR 5 mg and
40 mg, regression of plaques from baseline at the most diseased sites occurred
in 75% and 90% of patients, respectively .

through into

Since the company's founding in 1982, more than
4,000 organizations have taken advantage of FileNet solutions for help in
managing their mission-critical content and processes.

HILTON PRAGUE
Pobrezni 1, 186 00 Prague 8, Czech Republic
Telephone: +420 224 842 305
Fax: +420 224 842 741
http://www.

About FileNet
FileNet Corporation (Nasdaq: FILE) helps organizations make better
decisions by managing the content and processes that drive their business.com

"
"Speech analytics solutions overcome this knowledge barrier by
providing direct insight into the content of the customer relationship
and by providing trending information that directly supports the
business re-engineering process. SpeechMiner
utilizes Deliberate Listening(TM), the latest advances of speech
analytics technology and web-based software, to help contact centers
reduce call-handling time, increase sales performance, enhance
customer satisfaction , automate the quality management processes, and
provide a wide range of business intelligence from recorded
conversations.
Adverse reactions have usually been mild and transient.

insights sallust

Where and When:
FileNet EMEA UserNet 2005 Conference, June 1-3, 2005.
FileNet's Enterprise Content Management (ECM) solutions allow customers to
build and sustain competitive advantage by managing content throughout their
organizations, automating and streamlining their business processes, and
providing a spectrum of connectivity needed to simplify their critical and
everyday decision-making . - First of its kind ORION Study examines effects of statin therapy on plaque
composition using high-resolution MRI -

PRAGUE, Czech Republic, New data
presented today from ORION (Outcome of Rosuvastatin treatment on carotid
artery atheroma: a magnetic resonance Imaging ObservatioN) showed that CRESTOR
5 mg and 40 mg reduced the proportion of lipid-rich necrotic core (LRNC) in
the most diseased area of atherosclerotic plaques by 17.006), respectively.6% (p=NS) and 35. For patients with marked
hypercholesterolemia (LDL-C >190 mg/dL) and aggressive lipid targets , a 20-mg
starting dose may be considered. For more information about
AstraZeneca, please visit: http://www.

arts account

The Storage Forum will address the important issues of storage management
and information lifecycle management, and discuss how the FileNet P8 ECM
platform supports content storage and information lifecycle management
initiatives. For additional information about Utopy and its
award-winning SpeechMiner suite of products, visit www.utopy. The ORION study is novel in that we used advanced MRI
techniques to not only measure the size of atherosclerotic carotid arteries,
but also changes in the composition of the plaque following two years of
treatment with rosuvastatin.5% (-1.1%) at 5 mg and 40 mg respectively (p=NS). AstraZeneca licensed worldwide rights to
CRESTOR from the Japanese pharmaceutical company Shionogi + Co. It is
recommended that liver function tests be performed before and at 12 weeks
following both the initiation of therapy and any elevation of dose, and
periodically (e.3%), abdominal pain (1.

through conspiracy

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)